Morse Asset Management, Inc Emergent Bio Solutions Inc. Transaction History

Morse Asset Management, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$1.86 - $6.98 $26,412 - $99,116	14,200 New	14,200 $97,000
Q1 2019 May 02, 2019	SELL	$48.23 - $66.16 $1.3 Million - $1.79 Million	-27,050 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$55.63 - $73.24 $164,108 - $216,057	2,950 Added 12.24%	27,050 $1.6 Million
Q2 2018 Aug 15, 2018	BUY	$48.33 - $55.64 $540,329 - $622,055	11,180 Added 86.53%	24,100 $1.22 Million
Q1 2018 May 02, 2018	BUY	$44.44 - $54.39 $574,164 - $702,718	12,920 New	12,920 $680,000

159

33.7M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $463M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Morse Asset Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Morse Asset Management, Inc with notifications on news.